Schonfeld Strategic Advisors’s Cantel Medical Corporation CMD Stock Holding History

Schonfeld Strategic Advisors’s Portfolio CMD Stock Details CMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-5,200	Closed	-$415K	–	2534
2021 Q1	$415K	Buy	5,200 +1,400	+37%	+$109K	0.01%	1210
2020 Q4	$300K	Buy	+3,800	New	+$223K	﹤0.01%	1209
2020 Q2	–	Sell	-7,500	Closed	-$269K	–	1647
2020 Q1	$269K	Buy	+7,500	New	+$426K	0.02%	796
2018 Q3	–	Sell	-6,699	Closed	-$659K	–	1100
2018 Q2	$659K	Buy	+6,699	New	+$749K	0.04%	484

Schonfeld Strategic Advisors's CMD Position: Q2 2021 in Review

Schonfeld Strategic Advisors sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 5,200 shares — an estimated $415K sold.

Schonfeld Strategic Advisors first reported a position in CMD in Q2 2018 and held it in 4 quarters. The position peaked at $659K in Q2 2018. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.

Schonfeld Strategic Advisors reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
Schonfeld Strategic Advisors sold 5,200 Cantel Medical Corporation shares in Q2 2021, an estimated $415K.
Schonfeld Strategic Advisors first reported a position in Cantel Medical Corporation in Q2 2018 and held it in 4 quarters.
Schonfeld Strategic Advisors's Cantel Medical Corporation position peaked at $659K in Q2 2018.
0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.